Epidemiology, characteristics, treatments, and outcomes of adult-onset Still's disease in Afro-Caribbeans: Results from a population-based study in Martinique, French West Indies.


Journal

Journal of autoimmunity
ISSN: 1095-9157
Titre abrégé: J Autoimmun
Pays: England
ID NLM: 8812164

Informations de publication

Date de publication:
09 2023
Historique:
received: 13 03 2023
revised: 14 06 2023
accepted: 19 06 2023
medline: 22 8 2023
pubmed: 26 6 2023
entrez: 25 6 2023
Statut: ppublish

Résumé

To describe the epidemiology, characteristics, response to initial treatment, and outcomes of Adult-Onset Still's disease (AOSD) in the Afro-Caribbean population of Martinique with free and easy access to specialised care. We conducted a retrospective study from 2004 to 2022 in the island of Martinique, French West-Indies which total population was 354 800 in 2021. Patients were identified from multiple sources including standardised databases. To be included, patients had to be residents of the island and fulfilled Yamaguchi and/or Fautrel's criteria for AOSD, or have a compatible disease course, without a diagnosis of cancer, auto-immune disease or another auto-inflammatory disorder. Date of diagnosis, clinical and biological characteristics, treatments, and outcomes were collected. The prevalence was 7.6/100 000 inhabitants in 2021. The mean incidence was 0.4/100 000 during study period. Thirty-three patients (70.6% females) with a median follow-up of 35 months [7.5 to 119] were included. Twenty-six patients (78.8%) had a systemic pattern. Patients with a systemic monocyclic pattern had significantly more polyarticular involvement than patients with systemic polycyclic pattern (p = 0.016). Pulmonary involvement occurred in 51.5% of patients at diagnosis and systemic Pouchot score has been identified as an independent predictive factor for pulmonary involvement; OR of 3.29 [CI 95% 1.20; 9.01]. At first flare, all patients but one received oral glucocorticoids, 11 patients (32.4%) received intravenous glucocorticoids pulse and 12 patients (33%) received anti-IL1 therapy. Nineteen patients (57%) relapsed in a median time of 9 months [6 to 12] Three patients (9%) developed hemophagocytosis lymphohistiocytosis, fatal in 1 case. All deceased patients (n = 4, 11.76%) belonged to the systemic polycyclic pattern, with an event-free survival of 13.6 months [IQR 5.7; 29.5] CONCLUSION: AOSD in the Afro-Caribbean population of Martinique shares some similarities with other ethnic groups, but exhibit differences, such as a high proportion of lung involvement. Comparative studies are needed to confirm these results.

Identifiants

pubmed: 37356346
pii: S0896-8411(23)00095-1
doi: 10.1016/j.jaut.2023.103086
pii:
doi:

Substances chimiques

Glucocorticoids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103086

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Eleonore de Fritsch (E)

Department of Internal Medicine, Martinique University Hospital, Fort-de France, France.

Fabienne Louis-Sidney (F)

Department of Rheumatology, Martinique University Hospital, Fort-de-France, France; EpiCliV Research Unit, University of French West Indies, Martinique, France.

Arthur Felix (A)

Department of General Pediatrics, Competence Centre for Rare Pediatric Inflammatory Rheumatisms and Systemic Autoimmune Diseases (RAISE) Antilles-Guyane, Martinique University Hospital, Fort-de France, France.

Florence Moinet (F)

Department of Internal Medicine, Martinique University Hospital, Fort-de France, France.

Cécile Bagoée (C)

Department of Internal Medicine, Territorial Hospital Centre of New Caledonia, Nouméa, New Caledonia.

Kim Henry (K)

Department of Infectious Diseases, Cayenne Hospital, Guyane, France.

Sophie Wolff (S)

Department of Internal Medicine, Martinique University Hospital, Fort-de France, France.

Katlyne Polomat (K)

Department of Internal Medicine, Martinique University Hospital, Fort-de France, France.

Moustapha Dramé (M)

EpiCliV Research Unit, University of French West Indies, Martinique, France; Department of Clinical Research and Innovation, Martinique University Hospital, Fort-de-France, France.

Christophe Deligny (C)

Department of Internal Medicine, Martinique University Hospital, Fort-de France, France; EpiCliV Research Unit, University of French West Indies, Martinique, France.

Benoit Suzon (B)

Department of Internal Medicine, Martinique University Hospital, Fort-de France, France; EpiCliV Research Unit, University of French West Indies, Martinique, France. Electronic address: benoit.suzon@chu-martinique.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH